Periodic Reporting for period 1 - Cancer-Drug-Screen (High-throughput drug screening for identifying personalized cancer treatments tailored to the particular mutations of the patient’s tumor)

Our ERC-PoC funded project was aimed at creating products that improve the ability to select the right treatment for cancer patients based on the unique genetic makeup of their individual tumors. We focused on p53, as it is the most frequently mutated tumor suppressor gene in...